These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21297590)

  • 1. Action urged on foreign takeovers of Indian drugmakers.
    Padma TV
    Nat Med; 2011 Feb; 17(2):141. PubMed ID: 21297590
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugmakers and continuing medical education.
    Mehta PN
    Indian Pediatr; 2000 Jun; 37(6):626-30. PubMed ID: 10869142
    [No Abstract]   [Full Text] [Related]  

  • 3. Copycat consolidation.
    Wadman M
    Nature; 2007 Sep; 449(7161):393. PubMed ID: 17898741
    [No Abstract]   [Full Text] [Related]  

  • 4. Indian-born weapons for infectious diseases.
    Padmanaban G
    Nat Med; 2003 Jul; 9(7):813. PubMed ID: 12835687
    [No Abstract]   [Full Text] [Related]  

  • 5. CAN DRUGMAKERS LIVE WITHOUT MERGERS?
    Wieczner Y
    Fortune; 2015 Jun; 171(7):39-40. PubMed ID: 26242019
    [No Abstract]   [Full Text] [Related]  

  • 6. India in demand.
    Marris E
    Nature; 2005 Feb; 433(7028):902-3. PubMed ID: 15729350
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugmakers plow more resources into autism.
    Sheridan C
    Nat Biotechnol; 2013 May; 31(5):367-9. PubMed ID: 23657371
    [No Abstract]   [Full Text] [Related]  

  • 8. Outsourcing drug work. Pharmaceuticals ship R&D and clinical trials to India.
    Sinha G
    Sci Am; 2004 Aug; 291(2):24-5. PubMed ID: 15298112
    [No Abstract]   [Full Text] [Related]  

  • 9. Entering the contract research industry in India.
    Joseph J
    Contemp Clin Trials; 2008 May; 29(3):311-3. PubMed ID: 18053773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical research in China and India: a paradigm shift in drug development.
    Singh R
    Drug Discov Today; 2006 Aug; 11(15-16):675-6. PubMed ID: 16846793
    [No Abstract]   [Full Text] [Related]  

  • 11. [Astellas Pharma backs on innovations."Our claim is to compete with the best products on the market"].
    Eggert U; Marhoefer MB
    MMW Fortschr Med; 2010 Sep; 152(34-35):6-7. PubMed ID: 20923015
    [No Abstract]   [Full Text] [Related]  

  • 12. Indian biotechs partner with government.
    Jayaraman KS
    Nat Biotechnol; 2009 Apr; 27(4):305. PubMed ID: 19352355
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial publications.
    Bhatt AD
    Issues Med Ethics; 2000; 8(4):119-21. PubMed ID: 16323375
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 16. India: 50 years after independence.
    Miller DD; Nayak AR
    Nat Biotechnol; 1997 Aug; 15(8):727-9. PubMed ID: 9255782
    [No Abstract]   [Full Text] [Related]  

  • 17. Indian biogenerics industry emerges.
    Jayaraman KS
    Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract]   [Full Text] [Related]  

  • 18. Corporate research. Japan's drugmakers need a boost to compete.
    Normile D
    Science; 2002 May; 296(5571):1231. PubMed ID: 12016292
    [No Abstract]   [Full Text] [Related]  

  • 19. New patent rules drive Indian drug firms to research.
    Jayaraman KS
    Nat Med; 2005 Jan; 11(1):3. PubMed ID: 15635420
    [No Abstract]   [Full Text] [Related]  

  • 20. Research on hire.
    Gupta AS
    Issues Med Ethics; 2001; 9(4):111-3. PubMed ID: 16334912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.